Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire Uni-Bio Science Group and Medlink Builds Strategic Partnership Expansion of Value Chain towards Pharmaceutical E-commerce
Media-OutReach Newswire Uni-Bio Science Group, Sinopharm Weiqida Pharmaceutical and Suzhou Yingli Medical Technology Build Strategic Partnership on Acarbose Industry Value Chain
Media-OutReach Newswire Xlife Sciences AG: Active pharmaceutical ingredient for pneumonia caused by COVID-19 (coronavirus)